ANVISA
Anvisa prohibits eight cannabis products due to lack of registration
Anvisa approves new cannabis-based product in Brazil
“Extended deadline creates the possibility of presenting a more consistent proposal,” says Anvisa director about regulation of cultivation
One year after Anvisa's approval, MAPA still does not regulate veterinary cannabis
Anvisa Directors Signal in Meeting with Associations that Agency Should Meet STJ Deadline to Regulate Cannabis Cultivation
30/09/2025Representatives of associations who participated in the meeting with the entity confirmed the delivery of the draft ordinance by September 30; Anvisa has not yet officially stated whether it will comply with the deadline set by the Judiciary, which ends today
Anvisa and Embrapa evaluate authorization for cannabis research in Brazil
25/09/2025Meeting aligned strategies for the development of technical and scientific knowledge about the plant, focusing on its medicinal and industrial potential
Anvisa prohibits cannabis products; companies involved claim outdated information
23/09/2025Agency points out irregular sale on website, but former partner claims page has been offline for over a year
Public participation in Anvisa's regulatory agenda continues until September 15
12/09/2025Public consultation allows society to give opinions on the agency's priorities for the next two years; preliminary list does not include cannabis
More than 500 companies offer cannabis products to Brazil through importation; products now exceed 600
11/09/2025Anvisa points out the USA as the main supplier, followed by Canada, Colombia, and Uruguay
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
11/09/2025Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
11/09/2025Published by Anvisa, the new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Reblas Network includes cannabis product analysis; Brazil has 16 accredited laboratories
11/09/2025Published by Anvisa, new resolution expands the scope of the network of analytical laboratories and reinforces the quality control of cannabis-based products in the country
Anvisa has new approved directors
21/08/2025Confirmed appointments include Leandro Safatle, Thiago Campos, and Daniela Cerqueira
Anvisa Regulatory Agenda 2026 - 2027 opens space for society suggestions, including on cannabis
20/08/2025Population and regulated sectors have the opportunity to indicate topics of interest for the next biennium
Proposal to regulate cannabis cultivation is taken off Anvisa's meeting agenda
13/08/2025Decision postpones vote on new rules for cultivating low-THC varieties; new date for analysis not yet defined
Request for cannabis-based medicine without registration at Anvisa must be judged by the Federal Court
13/08/2025STJ decision reinforces federal jurisdiction for actions involving unregistered drugs at the regulatory agency